Mavorixafor
- PMID: 39626042
- Bookshelf ID: NBK609662
Mavorixafor
Excerpt
No information is available on the use of mavorixafor during breastfeeding. The manufacturer recommends not breastfeeding treatment and for three weeks after the final dose.
Similar articles
-
Tranexamic acid for preventing postpartum haemorrhage after caesarean section.Cochrane Database Syst Rev. 2024 Nov 13;11(11):CD016278. doi: 10.1002/14651858.CD016278. Cochrane Database Syst Rev. 2024. PMID: 39535297 Free PMC article. Review.
-
Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.MMWR Surveill Summ. 2022 Mar 11;71(5):1-29. doi: 10.15585/mmwr.ss7105a1. MMWR Surveill Summ. 2022. PMID: 35271557 Free PMC article.
-
Oral dextrose gel to prevent hypoglycaemia in at-risk neonates.Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012152. doi: 10.1002/14651858.CD012152.pub4. Cochrane Database Syst Rev. 2023. PMID: 38014716 Free PMC article. Review.
-
Upadacitinib.2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 32816423 Free Books & Documents. Review.
-
Copper Cu 64 Dotatate.2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 33497164 Free Books & Documents. Review.
Publication types
LinkOut - more resources
Full Text Sources